V Shepherd

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

R Powles, Jayesh Mehta, Samar Kulkarni et al. · The Lancet · 2000 · 355 citations

Medicine, Hematology, Oncology +14

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?

Seema Singhal, R Powles, J Treleaven et al. · Bone Marrow Transplantation · 2000 · 112 citations

Medicine, Hematology, Cell Therapy +13

High-dose busulphan/melphalan with autologous stem cell rescue in Ewing’s sarcoma

Ayad Atra, JS Whelan, Victor Calvagna et al. · Bone Marrow Transplantation · 1997 · 80 citations

Medicine, Oncology, Surgery +16

Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment

R Powles, Noopur Raje, B. C. Millar et al. · Bone Marrow Transplantation · 1997 · 65 citations

Medicine, Hematology, Oncology +8

Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation

Seema Singhal, R Powles, S Kulkarni et al. · Bone Marrow Transplantation · 2000 · 51 citations

Medicine, Hematology, Cell Therapy +10